课题基金 / 基金详情

EVALUATION OF CONTINUOUS INFUSION GALLIUM NITRATE FOR ADVANCED BLADDER CARCINOMA

EVALUATION OF CONTINUOUS INFUSION GALLIUM NITRATE FOR ADVANCED BLADDER CARCINOMA
连续输注硝酸镓治疗晚期膀胱癌的评估
批准号：
6246367
负责人：
ERIC J SMALL
金额：
$4.89万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-02-04 至 1997-11-30
来源：
https://reporter.nih.gov/project-details/6246367
关键词：
bladder neoplasm carcinoma clinical research drug administration rate /duration drug adverse effect drug screening /evaluation gallium human subject human therapy evaluation neoplasm /cancer chemotherapy neoplasm /cancer relapse /recurrence neoplastic process nitrates

项目摘要

项目成果

ERIC J SMALL的其他基金

相似基金

相关文献

中文摘要
翻译
研究者计划：1)评估的有效性和可行性
英文摘要
The investigators plan to: 1) Assess the efficacy and feasibility of utilizing gallium nitrate in patients who have progressed following cytotoxic chemotherapy with advanced or recurrent urothelial tract tumors, and 2) Evaluate the toxicity of gallium nitrate in this group of patients. The gallium nitrate is to be given by continuous infusion over 24 hrs for 7 consecutive days at start of each treatment cycle in the amount of 300 mg/m2/day. Patient must be hospitalized for first treatment cycle.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Predictive Markers in Metastatic Renal Cancer
PROSTATE CANCER PROGRAM
04557: A PHASE I/II STUDY OF DOCETAXEL/PREDNISONE AND PTK 787/ZK 222584 IN PR
EFFECTS OF BICALUTAMIDE MONOTHERAPY ON BONE DENSITY IN PROSTATE CANCER
海外基金